Labs
ACB - I've deleted it from my daily watch listThey expect their new shelf prospectus and reverse split to be completed on May 11. Based on last week's market cap, we would be looking at 35% dilution, but after yesterday's sell off, it is getting closer to 50%.
I had a buy box for a bounce play, but for the time being, I will be avoiding ACB like the plague. ACB and CGC, they once were kings of a promised land, and then, it all went bust. My money is safe with APHA, XLY, LABS, VLNS, and the USA based MSO's. Not with Acreage though. Perhaps I sound cynical, but this is a tough time for cannabis investors, and it requires a tough attitude and strong opinion. I act on what I see, not on what analysts tell me. One even suggests ACB is still a buy. Fundamentals and business strategy are key, and both CGC and ACB are lacking, for the time being.
LABS Earnings Next WeekWhat's in store for Q4 earnings? I have no idea. I do know that I like LABS a lot. As with my other favourites, solid fundamentals and high growth potential. Fell right through my target - I ended up buying twice - and then bounced nicely.
I am looking for a short term, sustained bounce towards $3.35 level, then gather some strength before moving higher again. If the broader markets continue to recover, I see LABS as a winner. If broader markets go for another round of selling, I believe my investment is safe here.
A growth stock with some value.
LABS Regression Trend| Higher Low| Key ResistanceHello Traders!
Today’s chart update will be on LABS – Canadian MJ – which has been trading in a clear regression trend, close to testing upper resistance, is a break imminent?
Points to consider,
- Clear bear trend
- Support provided by 50 MA
- Regression trend resistance to break
- Stochastics in lower regions
- RSI respecting trend
- Volume below average
LABS bear trend has been putting in consecutive lower highs, with a first higher low coming to fruition, a trend change may be probable.
Support is currently being provided by the 50 MA, all averages will eventually need to hold LABS when testing key resistance. The Regression trend resistance is a staunched area that LABS must close above to register for a probable trend change.
Stochastics are in the lower regions, can stay trading here for an extended period of time, however lots of stored momentum to the upside. The RSI is respecting its trend line, currently neutral, not at extreme ends. LABS volume needs to stay above average for continued follow though when breaking levels.
Overall, in my opinion, a break and close above key structural resistance will confirm a trend change. LABS, does need to increase volume otherwise a rejection at currently trading level will become more probable.
What are your thoughts?
Please leave a like and comment,
And remember,
“Trading effectively is about assessing probabilities, not certainties.”
― Yvan Byeajee
LABS - Breakout of pennant, macd crossover upThe only green stock in weed sector, although its extraction company. MACD crossover up and I think it can run for another day or two. VFF beat earnings, so the whole mj sector could be green 1 or 2 days. May 14th has more earnings from mj companies.
LABS looking pretty extended...Looks like some residual buying pressured forced LABS up to another daily higher high, before triggering expected profit taking. Levels on watch, but I would not want to be holding any position right now. We may see some healthy and reasonably overdue consolidation, perhaps looking for some FIB levels in anticipation of lower lows and lower highs.
Medipharm Labs Technical Analysis 16.02.19Dear Traders,
What a run for $LABS! I'm very happy for those who entered a long position around 1.95C$ you did an excellent job.
$LABS also retraced a bit after that first leg up, but the bulls are strong and a nice reversal occurred!
What now? Well, we did finish the week in a strong way, and indicators are showing buy signals all other the place.
$LABS recently announced great news, and there is plenty more to come!
Let's see what next weeks bring us! I'm still holding my position through the weekend, I'm very confident there is another leg up brewing.
Price Target: 3C$
LABS - Medipharm is looking ready to blow!Dear Traders,
Let's look at $LABS today.
I waited for this TA because I need confirmation, and look at this reversal! LABS shows its ready to pop!
In the interview Pat, the ceo of LABS, said there is good news coming! What a start of 2019 for this great company!
Keep your eyes on the charts!
KHIRON - Looking really charming!Dear Traders,
I hope all of you had a great X-Mas and drunk a lot during the new year's eve!
And I also hope lot's of you made good money in 2018!
If not, your doing something wrong or you simply did not have the gut to cut losses at one point.
Anyways to day let's have a look at KHRN for a Swing trade! Chart is looking really good on the 1Hr timeframe, Look at the Histogram MACD, showing bears getting less and less control!
I've recently decide to stay out of those big MJ companies such as CGC, ACB, APHA... The people trading them are the same in Crypto and that's just one huge manipulation game.
I've decided to look more into CBD companies like a like to call them, such as KHRN, KALY, LABS, TBP and many more! they all focus on exctracting high grade CBD, to using those exctracts to make medicine to cure diseases or to relieve pain! CBD is the future and those who deny that are very closed minded.
Will it be the next big hype?
Could be.
AM I to late to join?
Not in my opinion, a lot of companies are getting more and more talked about tho so if you don't want to miss a potential train, you should start to do some more research on those companies !
Just to let you know, I'm not a financial Advisor and just sharing this to you for information purposes only!
Take care all of you!
Canopy Growth Strategic Extract Supply Agreement With Medipharm!Dear Traders,
LABS got Halted pending on news, and what a news release!
I was waiting for Medipharm to release some news and we finally got some!
''Under the 18-month agreement, MediPharm will supply up to 900kg of cannabis extract for sale to Canopy Growth and its subsidiaries. Canopy Growth has committed to purchasing a minimum of 450kg with an option to purchase an additional 450kg.''
Now let's see how this plays off! 0.5 fib level resistance is at 1.88 C$ so if we have enough momentum, bulls could try to breakout to that price range!
MEDIPHARM - Looking Beatiful!Dear Traders,
Medipharm is looking like some sweet honey on a goat cheese cracker!
They announced some pretty nice things this month, they obtained their License and the day after they announce a Partnership with Supreme Cannabis! They will make sure Medipharm is equipped with the best High Grade Cannabis you can get to let medipharm create High Grade CBD Oils for the market!
Looking at the Daily Chart, We can see that Medipharms shows bullishness! Price action is now located above the main moving averages, so any entry around 1.50 is a pretty good one imo. With a stoploss under the 55 ma (blue line).
All Medipharm needs right now is some more vol! This stock could easily hit the million in volume, but it just needs more investors.
Let's see how this will playout on Monday. Will we get news again this week? Are more investor going to join?
Keep your eyes on the charts!
If you have any questions or any thoughts, feel free send me a PM or to comment on this TA!
If you'd like to join my Discord Channel to talk about stocks, share knowledge and have a laugh then please send me a PM so that I can link you to it!
Take care!
Medipharm - License + Partnership !Dear Traders,
Let's have a look at Medipharm.
MediPharm Labs Corp . (TSXV:LABS) is a leading B2B Canadian cannabis extractor, producing purified pharma-grade cannabis oil and concentrates for the development of cannabinoid derived products. As part of their B2B model, MediPharm Labs supplies raw materials, formulations, processing and packaging for ready-to-sell advanced derivative products. The first Canadian company to become a licensed producer of cannabis oil under the Access to Cannabis for Medical Purposes Regulations (ACMPR) without first being a licensed cultivator, MediPharm Labs is focused on bringing pharma-grade products to the adult-use and medical cannabis industries in Canada.
On the 12.11.18 they received their License approval and today, the 13.11.18 they announce a partnership with Supreme Cannabis:
'' ("Supreme Cannabis" or the "Company") (TSXV: FIRE) (OTCQX: SPRWF) (FRA: 53S1), is pleased to announce that the Company has entered into a three-year agreement with MediPharm Labs Inc . ("MediPharm"), a wholly owned subsidiary of MediPharm Labs Corp. (TSXV: LABS), to facilitate the launch of the Company's cannabis oil products line. MediPharm holds a processing license and is a leader in the cannabis industry focused exclusively on cannabis extraction and producing pharmaceutical-grade cannabis oil.
Supreme Cannabis, through its wholly-owned subsidiary, 7ACRES has agreed to supply a minimum of approximately 1,000 kg of high-quality cannabis trim as input per year to MediPharm for the extraction and production of at least 200,000 40ml units of premium, high-terpene cannabis oil products for the adult-use consumer market. Under the terms of this agreement, all cannabis oil products processed by MediPharm will be sold under Supreme Cannabis' brands, including a new, to be announced brand. The program will be established at no capital cost to Supreme Cannabis, with MediPharm receiving a processing fee based on the cannabis oil produced.
"We expected market segmentation as the Canadian cannabis industry evolved and the emergence of dedicated experts focused on downstream activities. Partnering with product experts, such as MediPharm, allows Supreme Cannabis to launch oil products quickly," said Navdeep Dhaliwal, CEO of Supreme Cannabis. "We are excited to be working with MediPharm and look forward to Canadian adult-use consumers being able to experience High End Cannabis™ oil products derived from what we believe is the best flower being produced at scale." ''
This is great news for both parties, and even more for Medipharm, this is a huge week for them and now they are finally ready to grow as a company and what a start!
Let's Talk Technical Analysis:
Price action has broken the first green line (today) showing great anticipation for a breakout. Our next target is the resistance showed on the graph. Bulls tried to go pass it twice, but failed due to no good motivation. With this news in play i'm pretty confident it will break. Once it does the price will stamble against the 0.382 fib level which will serve as a Resistance level aswell. I think we might see a first failed break due to the 10% run it had already, so I think it could drop towards our Resistance, which is now a support level as shown on the chart.
Once arrived there there should be a bounce, and another attempt to break. If Bulls do break above the 0.382 fib level, our next traget will be the 0.5 fib level, which would be a 18.25% run.
Let's see how it goes tomorrow, but I know I'll be watching Medipharm from close!
Any thoughts?
Feel free to leave me a PM if you'de like to join my Discord Channel where we traders talk, laugh and share knowledge!
Take care.
Medipharm Labs - Time for a Reversal ?Dear Traders,
Medipharm had some nice activity news wise this month and traders are buying again.
All I can see on the daily chart is that we are above the 50 RSI, which is bullish, on the hourly chart we are touching the 100 ma which will define if this is a reversal or not. If we succeed in holding above 1.60 then this could be a very good swing trade.
I entered at 1.58 and i'm waiting for some movement. All we need is some buying volume and this will go up !
MediPharm Labs Corp is a producer for cannabis oil production. The company is focused on downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification.
Any thoughts ?